Q56591907

article published in 1997

Q56591907 is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1052936104
P356DOI10.1023/A:1005303331218

P2093author name stringY. Tan
C.C. Chang
C.M. Lin
K.J. Hsiao
Y.M. Lee
P2860cites workReversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transferQ28115950
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemiaQ28291035
High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytesQ34003623
Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cellsQ34073981
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transductionQ34354588
Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiencyQ34454454
Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liverQ35559973
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenovirusesQ35837026
THE STRUCTURE OF THE PHENYLALANINE-HYDROXYLATION COFACTORQ36402585
Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous diseaseQ36470854
Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytesQ36757603
Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vectorQ37319132
Human dihydropteridine reductase: a method for the measurement of activity in cultured cells, and its application to malignant hyperphenylalaninemiaQ39286742
Inborn errors of pterin metabolismQ39548627
Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnanciesQ40364201
Second-generation adenovirus vectorsQ40939190
Somatic gene therapy for phenylketonuria and other hepatic deficienciesQ41180797
Molecular analysis of T lymphocyte-directed gene therapy for adenosine deaminase deficiency: long-term expression in vivo of genes introduced with a retroviral vectorQ41192415
Assessment of recombinant adenoviral vectors for hepatic gene therapyQ43425277
Adenovirus mediated expression of therapeutic plasma levels of human factor IX in miceQ43836200
Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelopeQ45767602
Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patientsQ45866834
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.Q45866838
Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.Q45867442
Preclinical studies of lymphocyte gene therapy for mild Hunter syndrome (mucopolysaccharidosis type II).Q45878645
Reconstitution of enzymatic activity in hepatocytes of phenylalanine hydroxylase-deficient miceQ45878913
Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivoQ45879739
Long-Term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient RabbitsQ45880751
Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuriaQ49313601
Treatment of phenylketonuria with a diet low in phenylalanine.Q52172881
Genetics and biochemistry of the phenylketonuria-present stateQ66972930
Prenatal diagnosis of "dihydrobiopterin synthetase" deficiency, a variant form of phenylketonuriaQ68908457
Intelligence and personality characteristics in adults with untreated atypical phenylketonuria and mild hyperphenylalaninemiaQ70678284
Umbilical cord blood transplantationQ71948181
P433issue6
P304page(s)742-754
P577publication date1997-01-01
P1433published inJournal of Inherited Metabolic DiseaseQ6295359
P478volume20

Reverse relations

cites work (P2860)
Q46536688Characterization of transgenic mice with the expression of phenylalanine hydroxylase and GTP cyclohydrolase I in the skin
Q44123143Comparison of epidermal keratinocytes and dermal fibroblasts as potential target cells for somatic gene therapy of phenylketonuria
Q40827772Development of a skin-based metabolic sink for phenylalanine by overexpression of phenylalanine hydroxylase and GTP cyclohydrolase in primary human keratinocytes
Q37221695Expression of phenylalanine hydroxylase (PAH) in erythrogenic bone marrow does not correct hyperphenylalaninemia in Pahenu2 mice
Q34325086Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer
Q45423981Reversal of gene expression profile in the phenylketonuria mouse model after adeno-associated virus vector-mediated gene therapy
Q42809966Towards metabolic sink therapy for mut methylmalonic acidaemia: correction of methylmalonyl-CoA mutase deficiency in T lymphocytes from a mut methylmalonic acidaemia child by retroviral-mediated gene transfer

Search more.